Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |